These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. [Factors affecting efficacy of proton pump inhibitors in NAID-induced gastric ulcers]. Karateev AE; Diukov IV Ter Arkh; 2007; 79(5):54-9. PubMed ID: 17672076 [TBL] [Abstract][Full Text] [Related]
51. Review article: proton pump inhibitors and bacterial overgrowth. Williams C; McColl KE Aliment Pharmacol Ther; 2006 Jan; 23(1):3-10. PubMed ID: 16393275 [TBL] [Abstract][Full Text] [Related]
52. First-time endoscopy and use of antisecretory medication: a population-based cohort study. Lassen A; Hallas J; De Muckadell OB Scand J Gastroenterol; 2005 Jun; 40(6):705-12. PubMed ID: 16036531 [TBL] [Abstract][Full Text] [Related]
53. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Jensen RT Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886 [TBL] [Abstract][Full Text] [Related]
54. Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors. Jayatilaka S; Shakov R; Eddi R; Bakaj G; Baddoura WJ; DeBari VA Ann Clin Lab Sci; 2007; 37(3):241-7. PubMed ID: 17709687 [TBL] [Abstract][Full Text] [Related]
55. Proton pump inhibitors and hospital discharge rates for gastrointestinal events in Italy: a national ecological study. Russo P; Brutti C Clin Ther; 2007 Apr; 29(4):751-8. PubMed ID: 17617299 [TBL] [Abstract][Full Text] [Related]
56. Comment: Proton pump inhibitor formulary considerations in the acutely ill. Part 1: pharmacology, pharmacodynamics, and available formulations. Conrad SA Ann Pharmacother; 2006 May; 40(5):997; author reply 997-8. PubMed ID: 16608907 [No Abstract] [Full Text] [Related]